Mauricio Castellon, MD
Plastic and Reconstructive Surgery · Melbourne, FLNPI 1881658144
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $10,270 of the $14,842 with a category attached, or 69.2%. AbbVie accounts for 82.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $11,455 and has fallen 95.8% since, to $484 in 2025.
Across 123 payments — averaging $120.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Sientra, Inc.$563
- Galderma Laboratories, L.p.$552
- Integra Lifesciences Corporation$476
- Musculoskeletal Transplant Foundation Inc.$239
- Dilon Technologies, Inc.$227
- plus $575 from 12 others
Across 2 payments — averaging $490.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$980
What the payments were for
- Speaking & faculty fees$9847%
- Food & beverage$3,26222%
- Gifts$10,27069%
- Other$3262%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 81 | $12,209 |
| Sientra, Inc. | 10 | $563 |
| Galderma Laboratories, L.p. | 3 | $552 |
| Integra Lifesciences Corporation | 2 | $476 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $239 |
| Dilon Technologies, Inc. | 5 | $227 |
| Revance Therapeutics, Inc. | 4 | $122 |
| Innovation Technologies Inc | 1 | $122 |
| Motiva USA, LLC | 1 | $120 |
| TELA Bio, Inc. | 2 | $48 |
| Bard Peripheral Vascular, Inc. | 1 | $31 |
| Medtronic | 1 | $30 |
| Tepha Inc | 1 | $23 |
| Stryker | 1 | $20 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $15 |
| Organogenesis Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,842 in reported general payments places this provider in the 80th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $249 |
| Ondansetron Hcl | 19 | $134 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Melbourne
- Alan DurkinVero Beach$548K
- Edgar SosaVero Beach$504K
- Vaishali DoolabhJacksonville$306K
- Sai Ramakrishna Velamuri VenkataTampa$303K
- Lee GibsteinBay Harbor Islands$216K
- John MurrayJacksonville$188K
- Arthur DesrosiersMiami$156K
- Miguel MedinaMiami$80K
- Roger KhouriCoconut Grove$80K
- George KamelFort Lauderdale$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.